This paper studies the contribution of doctor and patient "habit" to persistence in market shares in prescription drug markets. My unique panel dataset allows me to estimate the probability of switching brands as a function of patient and doctor attributes, with an emphasis on past prescribing behaviour so as to capture the degree of persistence. I find significant evidence of time-dependence in prescription choices for both doctors and patients, which seems to imply that in molecular submarkets in which brands are not allowed to compete on the basis of price, doctor and patient "habit" at the micro-level can translate into sticky and persistent market shares at the aggregate level. Copyright 2000 by Blackwell Publishing Ltd
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 48 (2000) Issue (Month): 3 (September) Pages: 349-69 Download reference. The following formats are available: HTML
(with abstract),
plain text
(with abstract),
BibTeX,
RIS (EndNote, RefMan, ProCite),
ReDIF
For technical questions regarding this item, or to correct its listing, contact: (Christopher F. Baum).
Related research
Keywords:
Cited by: (explanations, Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.)
Furu, Kari & Dalen, Dag Morten & Locatelli, Marilena & Strøm, Steinar, 2008.
"Generic Substitution,"
Memorandum
11/2008, Oslo University, Department of Economics.
[Downloadable!]